SCHEMBL21363792

SCHEMBL21363792

C=CCc1cc2c(cc1NCc1ccccc1C)OCO2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
ALDH1A1 P00352 7/20 0.42
GAA P10253 4/20 0.41
MAPT P10636 7/20 0.41
CYP1A2 P05177 3/20 0.41
CYP3A4 P08684 3/20 0.41
KDM4E B2RXH2 4/20 0.40
HTT P42858 4/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
NPC1 O15118 2/20 0.40
CYP2D6 P10635 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
USP2 O75604 1/20 0.40
CASP1 P29466 1/20 0.40
HBB P68871 1/20 0.40
HPGD P15428 3/20 0.39
ADRA2B P18089 1/20 0.38
ADRA2C P18825 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21363785 0.85 HPGD (0.45) MEN1KMT2AALDH1A1MAPTCYP1A2
SCHEMBL21363786 0.83 MAPT (0.48) MEN1KMT2AALDH1A1GAAMAPT
SCHEMBL21363678 0.75 CDK4 (0.45) MEN1KMT2AALDH1A1MAPTCYP1A2
SCHEMBL11696893 0.72 CYP3A4 (0.53) MEN1KMT2AALDH1A1GAAMAPT
SCHEMBL21363748 0.70 NPC1 (0.46) MEN1KMT2AALDH1A1MAPTCYP1A2
SCHEMBL87998 0.70 GABRA1 (0.47) KMT2AALDH1A1GAAMAPTADRA2B
SCHEMBL21363751 0.69 CYP1A2 (0.41) MEN1KMT2AALDH1A1MAPTCYP1A2
SCHEMBL21366573 0.69 NPC1 (0.54) MEN1KMT2AALDH1A1GAAMAPT
SCHEMBL21363749 0.69 CYP3A4 (0.43) MEN1KMT2AALDH1A1MAPTCYP1A2
SCHEMBL16681697 0.68 GABRA1 (0.45) KMT2AALDH1A1GAAMAPTADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019175712-A1 NEW USES FOR CATECHOL MOLECULES AS INHIBITORS TO GLUTATHIONE S-TRANSFERASE METABOLIC PATHWAYS BASF CORPORATION (US) 2019-09-19 WO disclosed
WO-2019175713-A1 NEW CATECHOL MOLECULES AND THEIR USE AS INHIBITORS TO P450 RELATED METABOLIC PATHWAYS BASF CORPORATION (US) 2019-09-19 WO disclosed